PET-CT en pacientes con cáncer de cuello uterino

Barbera L, Thomas G. Management of early and locally advanced cervical cancer. Semin Oncol. 2009;36(2):155-69.

https://doi.org/10.1053/j.seminoncol.2008.12.007

Schiffman M, Castle PE, Jerónimo J, Rodríguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890-907. Review.

https://doi.org/10.1016/S0140-6736(07)61416-0

Piñeros M, Murillo RH. Incidencia de cáncer en Colombia: Importancia de las fuentes de información en la obtención de cifras estimativas. Rev Colomb Cancerol. 2004;8(1):5-14.

Colombia, Instituto Nacional de Cancerología. Registro Institucional de Cáncer. En: Anuario Estadístico 2008. Bogotá: INC; 2008. p. 11-13.

Castellsagué X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008;110(3 Suppl 2):S4-S7. Review.

https://doi.org/10.1016/j.ygyno.2008.07.045

Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103-4.

https://doi.org/10.1016/j.ijgo.2009.02.012

Hacker NF. Revised FIGO staging for carcinoma of the vulva. Int J Gynaecol Obstet. 2009;105(2):105-6.

https://doi.org/10.1016/j.ijgo.2009.02.011

Grisaru D, Almog B, Levine C, Metser U, Fishman A, Lerman H, Lessing JB, Even-Sapir E. The diagnostic accuracy of 18F- uorodeoxyglucose PET/CT in patients with gynecological malignancies. Gynecol Oncol. 2004;94(3): 680-4.

https://doi.org/10.1016/j.ygyno.2004.05.053

Amit A, Beck D, Lowenstein L, Lavie O, Bar Shalom R, Kedar Z, et al. The role of hybrid PET/CT in the evaluation of patients with cervical cancer. Gynecol Oncol. 2006;100(1):65-9.

https://doi.org/10.1016/j.ygyno.2005.07.013

JW, Seo SS, Lee S, Kim JY, Kim SK, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer. 2006;106(4):914-22.

https://doi.org/10.1002/cncr.21641

Sironi S, Buda A, Picchio M, Perego P, Moreni R, Pellegrino A, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology. 2006;238(1):272-9.

https://doi.org/10.1148/radiol.2381041799

Loft A, Berthelsen AK, Roed H, Ottosen C, Lundvall L, Knudsen J, et al. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol. 2007;106(1):29-34.

https://doi.org/10.1016/j.ygyno.2007.03.027

Sironi S, Picchio M, Landoni C, Galimberti S, Signorelli M, Bettinardi V, et al., Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence. Eur J Nucl Med Mol Imaging, 2007;34(4):472-9.

https://doi.org/10.1007/s00259-006-0251-y

Chung HH, Park NH, Kim JW, Song YS, Chung JK, Kang SB. Role of integrated PET-CT in pelvic lymph node staging of cervical cancer before radical hysterectomy. Gynecol Obstet Invest. 2009;67(1):61-6.

https://doi.org/10.1159/000162101

Kitajima K, Murakami K, Yamasaki E, Domeki Y, Kaji Y, Sugimura K. Performance of FDG-PET-CT for diagnosis of recurrent uterine cervical cancer. Eur Radiol. 2008;18(10):2040-7.

https://doi.org/10.1007/s00330-008-0979-9

Yildirim Y, Sehirali S, Avci ME, Yilmaz C, Ertopcu K, Tinar S, et al. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT ndings. Gynecol Oncol. 2008;108(1):154-9.

https://doi.org/10.1016/j.ygyno.2007.09.011

Boughanim M, Leboulleux S, Rey A, Pham CT, Zafrani Y, Duvillard P, et al. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F] uorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol. 2008;26(15): 2558-61.

https://doi.org/10.1200/JCO.2007.14.3933

Kim SK, Choi HJ, Park SY, Lee HY, Seo SS, Yoo CW, et al. Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients. Eur J Cancer. 2009;45(12):2103-9.

https://doi.org/10.1016/j.ejca.2009.04.006

Chung HH, Park NH, Kim JW, Song YS, Chung JK, Kang SB. Role of integrated PET-CT in pelvic lymph node staging of cervical cancer before radical hysterectomy. Gynecol Obstet Invest. 2009;67(1):61-6.

https://doi.org/10.1159/000162101

Sofue K, Tateishi U, Sawada M, Maeda T, Terauchi T, Kano D, et al. Role of carbon-11 choline PET/CT in the management of uterine carcinoma: Initial experience. Ann Nucl Med. 2009;23(3):235-43.

https://doi.org/10.1007/s12149-009-0230-z

Tatsumi M, Cohade C, Bristow RE, Wahl RL. Imaging uterine cervical cancer with FDG-PET/CT: direct comparison with PET. Mol Imaging Biol. 2009;11(4):229-35.

https://doi.org/10.1007/s11307-008-0180-1

Choi EK, Kim JK, Choi HJ, Park SH, Park BW, Kim N, et al. Node-by-node correlation between MR and PET/CT in patients with uterine cervical cancer: diffusion-weighted imaging versus size-based criteria on T2WI. Eur Radiol, 2009;19(8):2024-32.

https://doi.org/10.1007/s00330-009-1350-5

Pandharipande PV, Choy G, Carmen MG, Gazelle GS, Russell AH, Lee SI, MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes. AJR. 2009;192(3):802-14.

https://doi.org/10.2214/AJR.08.1224

Kitajima K, Murakami K, Yamasaki E, Domeki Y, Kaji Y, Sugimura K. Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer. Eur Radiol. 2008;18(10):2040-7.

https://doi.org/10.1007/s00330-008-0979-9